Page 4 - Alessio Pappagallo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alessio pappagallo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alessio Pappagallo Today - Breaking & Trending Today

Chiesi USA announces new organizational leadership for the Chiesi Foundation

Provided by
GlobeNewswire
Maria Paola Chiesi, former Coordinator of the Foundation since 2010, succeeds Dr. Paolo Chiesi
CARY, N.C., May 13, 2021 (GLOBE NEWSWIRE) Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), announced that Maria Paola Chiesi was appointed President of the Chiesi Foundation, a non-profit organization established in 2005 as an expression of the corporate social responsibility of the Chiesi Group. Dedicated to research and international cooperation projects in the field of global health, the Foundation’s main objective is to promote access to neonatal and respiratory quality care in countries with low to medium levels of resources. ....

Burkina Faso , United States , North Carolina , United Kingdom , Emilia Romagna , Sierra Leone , Michael Wasyluk , Paolo Chiesi , Chiesi Farmaceutici , Alessio Pappagallo , Maria Paola Chiesi , Massimo Salvadori , B Corp , Chiesi Foundation , Group Chiesi , Chiesi Foundation Board Of Directors , Chiesi Foundation As Coordinator , Group Research , Coordinator Of The Foundation , Neonatal Essential Survival Technology , Chiesi Group , International Cooperation As Area Programme , Chiesi United States Inc , Value Sustainability Head Of The Chiesi Group , Certifiedb Corporation , Paola Chiesi ,

Chiesi Group calls for #ActionOverWords in the fight against climate change

Chiesi Group calls for #ActionOverWords in the fight against climate change
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

United States , France General , North Carolina , United Kingdom , Chiesi Actionoverwords , Michael Wasyluk , Chiesi Farmaceutici , Maria Paola Chiesi , Alessio Pappagallo , Group Research , Science Based Target Initiative , Sustainable Development Goals , Certifiedb Corp , Certifiedb Corporation , Chiesi Group Companies , B Corp , United Nations Framework Convention On Climate , Group Chiesi , B Corp Climate Collective , United Nations Framework Convention On Climate Change , B Lab , British Standards Institution , Chiesi Group , B Corp Directory , Chiesi United States Inc , B Corporation ,

Chiesi Group receives European Marketing Authorization for Trimbow® inhalation powder

Published: Apr 21, 2021
Chronic obstructive pulmonary disease (COPD) patients for whom a dry powder inhaler device is preferred, can now benefit from an extrafine formulation fixed triple combination therapy containing an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA) / long-acting muscarinic antagonist (LAMA) in a single device.
With this new European authorization, Chiesi reinforces its commitment to providing a broad portfolio of formulations and devices to COPD patients.
PARMA, Italy, April 21, 2021 (GLOBE NEWSWIRE) Chiesi, an international research-focused healthcare group (Chiesi Group), today announced that the European Commission has granted the marketing authorization for Trimbow® inhalation powder delivered through NEXThaler (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium), an extrafine formulation triple fixed combination therapy in a single dry powder inhaler (DPI), for the maintenance treatment in adult ....

United Kingdom , Alessandro Chiesi , Chiesi Farmaceutici , Alessio Pappagallo , European Lung Foundation , European Commission , Group Research , International Journal Of Chronic Obstructive Pulmonary Disease , European Union , Chiesi Group , B Corporation , Certifiedb Corporation , Chief Commercial Officer , Product Characteristics , Benefit Corporation , Dry Powder Inhaler , Pressurized Metered Dose Inhaler Formulations , Extrafine Beclomethasone , International Journal , Chronic Obstructive Pulmonary Disease , ஒன்றுபட்டது கிஂக்டம் , Alessandro சிஐசி , ஐரோப்பிய நுரையீரல் அடித்தளம் , ஐரோப்பிய தரகு , குழு ஆராய்ச்சி , சர்வதேச இதழ் ஆஃப் நாள்பட்ட தடைசெய்யும் நுரையீரல் நோய் ,